Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Assets AverageEnterprise ValueEquity AverageEquity RatioInterest Coverage RatioInvested CapitalReturn on AssetsReturn on Capital EmployedReturn on EquityTimes Interest Earned

Corbus Pharmaceuticals Holdings (CRBP) FCF Margin (2016 - 2021)

Corbus Pharmaceuticals Holdings has reported FCF Margin over the past 7 years, most recently at 880.53% for Q3 2021.

  • For Q3 2021, FCF Margin rose 309972.0% year-over-year to 880.53%; the TTM value through Jun 2022 reached 32631.18%, down 3036082.0%, while the annual FY2021 figure was 5470.98%, 346757.0% down from the prior year.
  • FCF Margin for Q3 2021 was 880.53% at Corbus Pharmaceuticals Holdings, up from 12835.99% in the prior quarter.
  • Over five years, FCF Margin peaked at 880.53% in Q3 2021 and troughed at 12835.99% in Q2 2021.
  • A 5-year average of 2286.68% and a median of 808.56% in 2017 define the central range for FCF Margin.
  • Biggest five-year swings in FCF Margin: surged 703513bps in 2019 and later crashed -924062bps in 2020.
  • Year by year, FCF Margin stood at 800.85% in 2017, then tumbled by -768bps to 6951.64% in 2018, then surged by 101bps to 83.49% in 2019, then crashed by -1365bps to 1055.93% in 2020, then skyrocketed by 183bps to 880.53% in 2021.
  • Business Quant data shows FCF Margin for CRBP at 880.53% in Q3 2021, 12835.99% in Q2 2021, and 3366.58% in Q1 2021.